Search Immortality Topics:

Page 21234..1020..»

Nanotechnology Market SWOT Analysis and Surge from 2019-2025 | Nanosys Inc., Nanophase Technologies Corporation, Altair Nanotechnologies Inc.,…

Posted: November 11, 2019 at 9:45 am

Global Nanotechnology market 2019-2025 in-depth study accumulated to supply latest insights concerning acute options. The report contains different predictions associated with Nanotechnology market size, revenue, production, CAGR, consumption, profit margin, price, and different substantial factors. Whereas accentuation the key driving and Nanotechnology restraining forces for this market, the report offers trends and developments. It additionally examines the role of the leading Nanotechnology market players concerned within the business together with their company summary, monetary outline and SWOT analysis.

The objective of Nanotechnology report is to outline, segment, and project the market on the idea of product types, application, and region, and to explain the factors concerning the factors influencing global Nanotechnology market dynamics, policies, economics, and technology etc.

Request Sample Report at: http://www.marketresearchglobe.com/request-sample/1014494

Nanosys Inc., Nanophase Technologies Corporation, Altair Nanotechnologies Inc., ZyvexCorporation, Acusphere Inc., Bruker Nano GmbH, Unidym Inc. (subsidiary of WisePower Co.), Ablynx, Advanced Diamond Technologies Inc., SouthWestNanoTechnologies Inc., PEN Inc

Get Customization & Check Discount for Report: http://www.marketresearchglobe.com/check-discount/1014494

Various analysis techniques applied to provide Nanotechnology information on competitors strategies; past data, and future sales and market trends. Business owners coming up with the current customers and reaching the target Nanotechnology market can benefit of the analytical information from different regions, to derive dynamic shifts. That are believed to global Nanotechnology market transformative influence on future sales. Insights on wherever the Nanotechnology market ought to be heading throughout the forecast, 2019 to 2025 and major players in the business.

Enquire Additional Concerning the Report at: http://www.marketresearchglobe.com/send-an-enquiry/1014494

Customization of this Report:

This report is bespoken to satisfy up with the customers necessities. Please contact our sales team (sales@marketresearchglobe.com), Which can assist you in getting that works for your desires.

Read more from the original source:
Nanotechnology Market SWOT Analysis and Surge from 2019-2025 | Nanosys Inc., Nanophase Technologies Corporation, Altair Nanotechnologies Inc.,...

Recommendation and review posted by G. Smith

Specialty MED Training Unveils New Physician Membership Program Community of Like-Minded Physicians to Share, Learn and Grow in Regenerative Medicine…

Posted: November 11, 2019 at 9:43 am

Physicians are flocking to learn more about regenerative therapies, from Platelet Rich Plasma (PRP) and shockwave therapy to pharmaceutical peptides, stem cells, exosomes and all the benefits that the current science provides, not only for their patients, but for the health of their practice. To meet the growing need for continuing education and peer-to-peer collaboration, Specialty MED Training developed a community network of like-minded physicians conducting research and sharing ideas to advance the application of functional, regenerative, sexual and aesthetic medicine.

DELRAY BEACH, Fla. (PRWEB) November 11, 2019

Specialty Med Training, (SMT) one of the nation's largest training, research and marketing companies, will unveil a brand new entry opportunity for practitioners into its national membership program at the 27th World Congress on Anti-Aging Medicine (A4M) in Las Vegas, NV on December 13-15, 2019.

Physicians are flocking to learn more about regenerative therapies, from Platelet Rich Plasma (PRP) and shockwave therapy to pharmaceutical peptides, stem cells, exosomes and all the benefits that the current science provides, not only for their patients, but for the health of their practice. To meet the growing need for continuing education and peer-to-peer collaboration, Specialty MED Training developed a community network of like-minded physicians conducting research and sharing ideas to advance the application of functional, regenerative, sexual and aesthetic medicine.

"For most physicians, learning the procedures is the easy part," said Joseph Banno, MD. Chief Education Director for Specialty MED Training and board-certified urologist at Midwest Urology in Peoria Illinois. "Successful implementation into the clinical practice is by far the bigger challenge. We have taken the learning curve out of equation. Our network members receive a tremendous amount of support from direct access to our board of clinical educators to world class marketing programs that drive patients in the door."

Specialty MED providers are leading the path towards evidence-based medicine and committed to educating practitioners on the science surrounding regenerative medicine while promoting an ethical and responsible approach to new applications.

Membership Privileges include:

To learn how you can become a member, visit specialtymedtraining.com or call 561-408-7248.

About Specialty Med Training

Specialty MED Training (SMT) is a national training, research and marketing company; dedicated to helping physicians bring the latest regenerative therapies and treatment options to their patients. They are actively building a national network of leading providers committed to the ethical and responsible advancement of the use of regenerative therapies in clinical practice.

For the original version on PRWeb visit: https://www.prweb.com/releases/specialty_med_training_unveils_new_physician_membership_program_community_of_like_minded_physicians_to_share_learn_and_grow_in_regenerative_medicine/prweb16710127.htm

Follow this link:
Specialty MED Training Unveils New Physician Membership Program Community of Like-Minded Physicians to Share, Learn and Grow in Regenerative Medicine...

Recommendation and review posted by G. Smith

AVITA Medical Added to S&P/ASX 200 Index – Business Wire

Posted: November 11, 2019 at 9:43 am

VALENCIA, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)--AVITA Medical (ASX: AVH) (NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, announced today that the company will be added to the S&P/ASX 200 index, effective upon market open on 14 November 2019, two months after being added to the S&P/ASX 300 index.

AVITA Medicals inclusion in the S&P/ASX 200 index is a testament to the companys solid growth trajectory following our U.S. commercialization of the RECELL System combined with the strength of our de-risked pipeline of future indications beyond burns, said Dr. Mike Perry, AVITA Medicals Chief Executive Officer. We believe the market capitalization and trading liquidity of the company will continue to grow as we advance our research and development efforts to realize the full potential of our innovative regenerative medicine technology platform.

The S&P/ASX 200 Index is recognized as the institutional investable benchmark in Australia and measures the performance of the largest 200 companies based on float-adjusted market capitalization on the Australian Securities Exchange.

ABOUT AVITA MEDICAL LIMITED

AVITA Medical is a regenerative medicine company with a technology platform positioned to address unmet medical needs in burns, chronic wounds, and aesthetics indications. AVITA Medicals patented and proprietary collection and application technology provides innovative treatment solutions derived from the regenerative properties of a patients own skin. The medical devices work by preparing a REGENERATIVE EPIDERMAL SUSPENSION (RES), an autologous suspension comprised of the patients skin cells necessary to regenerate natural healthy epidermis. This autologous suspension is then sprayed onto the areas of the patient requiring treatment.

AVITA Medicals first U.S. product, the RECELL System, was approved by the U.S. Food and Drug Administration (FDA) in September 2018. The RECELL System is indicated for use in the treatment of acute thermal burns in patients 18 years and older. The RECELL System is used to prepare Spray-On Skin Cells using a small amount of a patients own skin, providing a new way to treat severe burns, while significantly reducing the amount of donor skin required. The RECELL System is designed to be used at the point of care alone or in combination with autografts depending on the depth of the burn injury. Compelling data from randomized, controlled clinical trials conducted at major U.S. Burn Centers and real-world use in more than 8,000 patients globally, reinforce that the RECELL System is a significant advancement over the current standard of care for burn patients and offers benefits in clinical outcomes and cost savings. Healthcare professionals should read the INSTRUCTIONS FOR USE - RECELL Autologous Cell Harvesting Device (https://recellsystem.com/) for a full description of indications for use and important safety information including contraindications, warnings and precautions.

In international markets, our products are marketed under the RECELL System brand to promote skin healing in a wide range of applications including burns, chronic wounds and aesthetics. The RECELL System is TGA-registered in Australia and received CE-mark approval in Europe.

To learn more, visit http://www.avitamedical.com.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This letter includes forward-looking statements. These forward-looking statements generally can be identified by the use of words such as anticipate, expect, intend, could, may, will, believe, estimate, look forward, forecast, goal, target, project, continue, outlook, guidance, future, other words of similar meaning and the use of future dates. Forward-looking statements in this letter include, but are not limited to, statements concerning, among other things, our ongoing clinical trials and product development activities, regulatory approval of our products, the potential for future growth in our business, and our ability to achieve our key strategic, operational and financial goal. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Each forward- looking statement contained in this letter is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statement. Applicable risks and uncertainties include, among others, the timing of regulatory approvals of our products; physician acceptance, endorsement, and use of our products; failure to achieve the anticipated benefits from approval of our products; the effect of regulatory actions; product liability claims; risks associated with international operations and expansion; and other business effects, including the effects of industry, economic or political conditions outside of the companys control. Investors should not place considerable reliance on the forward-looking statements contained in this letter. Investors are encouraged to read our publicly available filings for a discussion of these and other risks and uncertainties. The forward-looking statements in this letter speak only as of the date of this release, and we undertake no obligation to update or revise any of these statements.

See the rest here:
AVITA Medical Added to S&P/ASX 200 Index - Business Wire

Recommendation and review posted by G. Smith

Therapeutics Solutions International Signs Agreement With Beijing Regenesis Biotechnology to License and Develop Patent for Anti-aging Use of Cord…

Posted: November 11, 2019 at 9:43 am

OCEANSIDE, California, Nov. 11, 2019 /PRNewswire/ -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announced today the signing of a Letter of Intent with Beijing Regenesis Biotechnology Co. Ltd., of Beijing China to develop and commercialize the anti-aging properties of cord blood plasma combined with NanoStilbene.

"Our Company is the leading entity in implementation of anti-aging regenerative medicine in China. We have previously commercialized novel technologies for rejuvenation of testicular and ovarian function," said Dr. Fei Li, Chief Executive Officer of Beijing Regenesis. "Cord blood components have been used for more than a Century in medicine with an excellent safety profile. We are excited to utilize the new technology developed by TSOI in order to reduce and potentially even reverse the biological aspects of aging."

"Having previously collaborated with Beijing Regenesis, I am excited to expand our work in the area of anti-aging medicine.There are publications from Stanford University[1] andHarvard University[2] that have shown that if the circulation of an aged mouse is connected to the circulation of a young mouse, various factors secreted by young mice induce an anti-aging/rejuvenating effect on organs/tissues of aged mice. Following this logic, other studies have demonstrated that human cord blood plasma, when administered to aged mice results in restoration of brain function and improved cellular function in the hippocampus[3]," said Dr. Feng Lin, Chief Scientific Officer of TSOI. "We are very excited to commercialize the use of cord blood plasma with NanoStilbene as a means of translating the animal parabiosis experiments into humans."

"Our Company is about fast forwarding the development of novel medical technologies. Based on the reputation, success, and ingenuity of Beijing Regenesis, we believe we have found an ideal commercialization partner," said Timothy Dixon, President and Chairman of TSOI. "We are especially grateful for Congressional Candidate Famela Ramos, our Director of Business Development, for having arranged our meeting and providing an excellent venue for signing of the Letter of Intent."

About Therapeutic Solutions International, Inc.Therapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases. Immune modulation refers to the ability to upregulate (make more active) or downregulate (make less active) one's immune system. The Company's corporate website is http://www.therapeuticsolutionsint.comand e-commerce at http://www.youcanordernow.com.

Safe Harbor Statement

This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous risk factors as set forth in our SEC filings. To the extent that statements in this press release are not strictly historical, including statements as to product launch timing, revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future collaboration agreements, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made.

References:

[1] Conboy et al.Rejuvenation of aged progenitor cells by exposure to a young systemic environment.Nature. 2005 Feb 17;433(7027):760-4.https://www.ncbi.nlm.nih.gov/pubmed/15716955

[2] Katsimpardi et al.Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors.Science. 2014May 9;344(6184):630-4.https://www.ncbi.nlm.nih.gov/pubmed/24797482

[3] Castellano et al. Human umbilicalcordplasmaproteins revitalize hippocampal function in agedmice. Nature2017 Apr 27;544(7651):488 492.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586222/

CONTACT INFORMATION

Therapeutic Solutions International, Inc.ir@tsoimail.com+1(760)295-7208 Timothy Dixon

SOURCE Therapeutic Solutions International, Inc.

Home

More:
Therapeutics Solutions International Signs Agreement With Beijing Regenesis Biotechnology to License and Develop Patent for Anti-aging Use of Cord...

Recommendation and review posted by G. Smith

Beyond the genome: RNA control of stem cells – Science Magazine

Posted: November 11, 2019 at 9:43 am

Tissue-resident stem cells are important for maintaining proper organ and tissue function throughout the lifetime of mammals. Although some types of stem cells constantly proliferate and give rise to committed progeny, such as intestine and skin, others reside mainly in a quiescent (noncycling) state, such as skeletal muscle. How stem cells maintain their quiescence while contributing to homeostatic tissue turnover is not well understood and is an active topic of investigation because of the potential of stem cell biology in regenerative medicine and healthy aging (1). On page 734 of this issue, de Morree et al. (2) characterize the underlying mechanisms that control muscle stem cell (MuSC) behavior in mice. Unexpectedly, they show that multiple species of RNAs coordinately confer precise regulation of quiescence and proliferation in MuSCs under homeostatic conditions.

Continue reading here:
Beyond the genome: RNA control of stem cells - Science Magazine

Recommendation and review posted by G. Smith

An artist and a transplant researcher discuss the heart – Harvard Gazette

Posted: November 11, 2019 at 9:43 am

Doris A. Taylors so-called replacement ghost heart suggests something otherworldly, but the eerie-looking form is far from an apparition. Its an innovative approach to organ transplantation that has inspired many in the medical community and at least one artist.

The Texas researchers process piggybacks on natures sophisticated design. Together she and a team of researchers strip cells off human and animal cadaver hearts with a soapy solution, leaving ghostly white protein shells that retain the form of the organ. They inject them with a patients blood or bone-marrow stem cells, and the ghost hearts act as scaffolding on which the newly introduced cells can slowly transform into a beating muscle.

What we said was, Wouldnt it be really cool if we could wash the sick cells out and put the healthy cells back in? said Taylor, director of Regenerative Medicine Research and director of the Center for Cell and Organ Biotechnology at the Texas Heart Institute, during a recent talk at the Radcliffe Institute for Advanced Study.

The hope is that one day these regenerated hearts will resolve the most challenging issues transplant patients currently face: the lack of a permanent artificial replacement, concerns about rejection, and the shortage of viable donor hearts.

Taylors efforts are driving what could become a revolution in organ transplants, and they have sparked the creativity of transdisciplinary artist Dario Robleto, whose latest work, on view at the Johnson-Kulukundis Family Gallery in Radcliffes Byerly Hall, recreates in images and sounds the original pulse wave of the heart first captured in visual form by scientists in the 1900s. Robleto and Taylor, longtime friends and Texas residents, explored those connections during Mondays Radcliffe discussion, which was moderated by Jennifer Roberts, Elizabeth Cary Agassiz Professor of the Humanities.

Robletos exhibit, Unknown and Solitary Seas, touches on the overlap between the medical mysteries and workings of the vascular pump, and the metaphor for the heart as the emotional center of the soul. It includes a video installation that features recreated sounds of a beating heart from the 19th century, reconstructed images of how the earliest pulse waves first appeared on the page, and a series of heart waveform sculptures in brass-plated stainless steel.

Roberts said that with his work, Robleto acknowledges the pulse waves promise, their profundity, their scientific value, but he also reclaims some of their ambiguity and asks us to wonder whether we can or should accept that these waveforms have escaped the realms of art, culture, and emotional communication.

Taylor similarly views her work as a blend of the scientific and the human. It transcends complicated, complex science, she says, in that her ghost hearts require a kind of passion, commitment, care, attention, and nurturing similar to whats required by a small child. Its really about building hearts at the emotional, mental, spiritual, and physical level that I think is going to get them to work, she said.

For Robleto, big ideas, like the creation of a new human heart, require multiple perspectives.

The artist called Taylors work one of the most fascinating and definitely one of the most emotional things Ive ever seen. As an object, he added, the ghost heart is stunningly beautiful but it also raises questions about the self, identity, emotion, the notions of form and where memory is truly held, questions he thinks artists can help address. He cited two of the nations earliest heart transplants, after which the patients wives asked their husbands, who had received donor hearts, if they still loved them.

Taylors work, Robleto said, is right at the edge of identity and materiality and so when the day comes when someone says the first ghost heart transplant I think we will have a similar moment where perhaps we will be forced to re-evaluate what we ask from our heart metaphor.

Dario Robletos Unknown and Solitary Seas is on view in Byerly Halls Johnson-Kulukundis Family Gallery through Jan. 18, 2020.

See more here:
An artist and a transplant researcher discuss the heart - Harvard Gazette

Recommendation and review posted by G. Smith


Page 21234..1020..»